INTERFERON-ALPHA AND TRANSFER-FACTOR IN THE TREATMENT OF MULTIPLE-SCLEROSIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
MCLEOD, JG
机构：
来源：
RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY | 1989年 / 863卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：125 / 130
页数：6
相关论文
共 50 条
  • [41] ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study) A Randomized, Double-Blind, Placebo-Controlled Trial
    Torkildsen, Oivind
    Wergeland, Stig
    Bakke, Soren
    Beiske, Antonie G.
    Bjerve, Kristian S.
    Hovdal, Harald
    Midgard, Rune
    Lilleas, Finn
    Pedersen, Tom
    Bjornara, Bard
    Dalene, Froydis
    Kleveland, Grethe
    Schepel, Jan
    Olsen, Inge Christoffer
    Myhr, Kjell-Morten
    ARCHIVES OF NEUROLOGY, 2012, 69 (08) : 1044 - 1051
  • [42] A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus
    Westerberg, BD
    Roberson, JB
    Stach, BA
    AMERICAN JOURNAL OF OTOLOGY, 1996, 17 (06): : 896 - 903
  • [43] Treatment of idiopathic oligozoospermia with an alpha-blocker: A placebo-controlled double-blind trial
    Gregoriou, O
    Vitoratos, N
    Papadias, C
    Gargaropoulos, A
    Konidaris, S
    Giannopoulos, V
    Chryssicopoulos, A
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 1997, 42 (05): : 301 - 305
  • [44] A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
    Vitton, O
    Gendreau, M
    Gendreau, J
    Kranzler, J
    Rao, SG
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 : S27 - S35
  • [45] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ACITRETIN FOR THE TREATMENT OF PSORIASIS
    OLSEN, EA
    WEED, WW
    MEYER, CJ
    COBO, LM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (04) : 681 - 686
  • [46] Human leukocyte interferon-alpha in a hydrophilic gel for the treatment of genital warts in women - A placebo-controlled, double-blind study.
    Syed, TA
    Ahmad, SA
    Cheema, KM
    CLINICAL CHEMISTRY, 1996, 42 (06) : 623 - 623
  • [47] A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis
    Romine, JS
    Sipe, JC
    Koziol, JA
    Zyroff, J
    Beutler, E
    PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (01) : 35 - 44
  • [48] Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
    Kappos, Ludwig
    Hartung, Hans-Peter
    Freedman, Mark S.
    Boyko, Alexey
    Radue, Ernst Wilhelm
    Mikol, Daniel D.
    Lamarine, Marc
    Hyvert, Yann
    Freudensprung, Ulrich
    Plitz, Thomas
    van Beek, Johan
    LANCET NEUROLOGY, 2014, 13 (04): : 353 - 363
  • [49] INTERFERON-ALPHA IS EFFECTIVE IN THE TREATMENT OF HIV-1-RELATED, SEVERE, ZIDOVUDINE-RESISTANT THROMBOCYTOPENIA - A PROSPECTIVE, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    MARRONI, M
    GRESELE, P
    LANDONIO, G
    LAZZARIN, A
    COEN, M
    VEZZA, R
    SINNONE, MS
    BOSCHETTI, E
    NOSARI, AM
    STAGNI, G
    NENCI, GG
    PAULUZZI, S
    ANNALS OF INTERNAL MEDICINE, 1994, 121 (06) : 423 - 429
  • [50] SYSTEMIC INTERFERON-ALPHA IN MULTIPLE-SCLEROSIS
    WEINSHENKER, BG
    EBERS, GC
    ARCHIVES OF NEUROLOGY, 1989, 46 (03) : 251 - 252
12345